Autoimmune Hemolytic Anemia and Pulmonary Embolism: An Association to Consider

Autoimmune hemolytic anemia (AIHA) is increasingly recognized as a strong risk factor for venous thrombosis. However, there are currently no guidelines on thromboembolism prevention and management during AIHA. Here, we describe the case of a patient with AIHA and pulmonary embolism and resume the cu...

Descripción completa

Detalles Bibliográficos
Autores principales: Solari, Daria, Alberio, Lorenzo, Ribi, Camillo, Grandoni, Francesco, Stalder, Gregoire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811891/
https://www.ncbi.nlm.nih.gov/pubmed/33469565
http://dx.doi.org/10.1055/s-0040-1721733
Descripción
Sumario:Autoimmune hemolytic anemia (AIHA) is increasingly recognized as a strong risk factor for venous thrombosis. However, there are currently no guidelines on thromboembolism prevention and management during AIHA. Here, we describe the case of a patient with AIHA and pulmonary embolism and resume the current knowledge on epidemiology, risk factors, treatment, and pathophysiology of thrombosis during AIHA, as well as new therapeutic perspectives to prevent thrombus formation during AIHA.

Ejemplares similares